Harrow Health, Inc. 11.875% Senior Notes due 2027 (HROWM) Stock Overview
Explore Harrow Health, Inc. 11.875% Senior Notes due 2027’s financial performance, market position, analyst ratings, and future outlook.
Harrow Health, Inc. 11.875% Senior Notes due 2027 (HROWM)
Key Financials
Key Financials
Market Cap
1.3B
P/E Ratio
-105.30
EPS (TTM)
N/A
ROE
-0.34%
HROWM Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Harrow Health, Inc. 11.875% Senior Notes due 2027 (HROWM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $24.90.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -105.30 and a market capitalization of 1.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.